A significant proportion of medicines are prescribed “off-label”. Targeting these cases will have detrimental treatment effects – medicine isn’t black and white. Scott Gottlieb writes:
It is true that some off-label drug use is based on very unsettled science and has more risks. But medicine — and not just cancer care — involves lots of hard choices.
